New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 11, 2013
10:12 EDTCIEN, VRSN, ROSE, SLXP, TAP, DHI, WPZ, PANW, OKSB, OC, MAS, AOL, GWAY, ABT, DISCA, SSTK, MRH, GMT, SCOR, AIGOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AIG (AIG) initiated with an Outperform at FBR Capital... AOL (AOL) initiated with a Hold at Cantor... comScore (SCOR) initiated with a Hold at Cantor... D.R. Horton (DHI) initiated with a Buy at BofA/Merrill... GATX Corp. (GMT) initiated with a Buy at Stifel Nicolaus... Masco (MAS) initiated with a Buy at BofA/Merrill... Molson Coors (TAP) initiated with a Buy at Nomura... Montpelier Re (MRH) initiated with a Market Perform at JMP Securities... Owens Corning (OC) initiated with a Buy at BofA/Merrill... Salix (SLXP) initiated with an Outperform at RBC Capital... Shutterstock (SSTK) initiated with a Buy at Cantor... Southwest Bancorp (OKSB) initiated with a Buy at DA Davidson... Rosetta Resources (ROSE) initiated with an Overweight at Stephens... Discovery (DISCA) coverage resumed with a Neutral at JPMorgan... Palo Alto (PANW) initiated with a Neutral at B. Riley Caris... VeriSign (VRSN) initiated with a Neutral at B. Riley Caris... Abbott (ABT) initiated with an Equal Weight at Barclays... Williams Partners (WPZ) initiated with a Buy at Global Hunter... Ciena (CIEN) initiated with a Buy at Maxim... Greenway Medical (GWAY) initiated with a Buy at Sidoti.
News For AIG;SCOR;AOL;DHI;GMT;MAS;TAP;MRH;OC;SLXP;SSTK;OKSB;ROSE;DISCA;PANW;VRSN;ABT;WPZ;CIEN;GWAY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
February 23, 2015
09:59 EDTSLXPOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Antofagasta (ANFGY) downgraded to Sell from Neutral at Goldman... Arch Coal (ACI) downgraded to Sell from Buy at Argus... BHP Billiton (BHP) downgraded to Equal Weight from Overweight at Morgan Stanley... Beazer Homes (BZH) downgraded to Neutral from Buy at Compass Point... Boeing (BA) downgraded to Sell from Neutral at Goldman... Century Communities (CCS) downgraded to Neutral from Overweight at JPMorgan... CyberArk (CYBR) downgraded to Underweight from Neutral at JPMorgan... DirecTV (DTV) downgraded to Hold from Buy at Brean Capital... Enerplus (ERF) downgraded to Hold from Buy at Desjardins... Fiserv (FISV) downgraded to Neutral from Buy at Monness Crespi... GP Strategies (GPX) downgraded to Neutral from Buy at B. Riley... Interactive Brokers (IBKR) downgraded to Market Perform at Keefe Bruyette... MRC Global (MRC) downgraded at BB&T... Precision Castparts (PCP) downgraded to Neutral from Buy at Goldman... Quest Diagnostics (DGX) downgraded at BofA/Merrill... Rio Tinto (RIO) downgraded to Equal Weight from Overweight at Morgan Stanley... Roth Capital downgraded Spectrum (SPPI) on court case loss... Royal Dutch Shell (RDS.A) downgraded to Sector Perform from Outperform at Howard Weil... Ryland Group (RYL) downgraded to Neutral from Buy at Compass Point... Salix (SLXP) downgraded to Market Perform from Outperform at Leerink... Standard Pacific (SPF) downgraded to Neutral from Buy at Compass Point... Superior Energy (SPN) downgraded to Neutral from Outperform at Credit Suisse... Transocean (RIG) downgraded to Negative from Neutral at Susquehanna... Vale (VALE) downgraded to Equal Weight from Overweight at Morgan Stanley.
09:12 EDTDISCADiscovery volatility flat into 21st Century Fox denied it held talks
Subscribe for More Information
08:27 EDTPANWPalo Alto price target raised to $150 from $130 at Pacific Crest
Subscribe for More Information
07:55 EDTSLXPJefferies says other bidders may emerge for Salix
Jefferies says it could envision other bidders emerging for Salix (SLXP) and points out recent media reports have suggested Shire (SHPG) and Endo (ENDP) have considered making a bid for the company. It lists AstraZeneca (AZN) and Takeda as others who could have possible interest in Salix. The firm believes Valeant (VRX) could afford to pay more for Salix should other bidders emerge.
07:41 EDTSLXPValeant buyout of Salix another smart deal, says UBS
Subscribe for More Information
07:13 EDTSLXPSalix downgraded to Market Perform from Outperform at Leerink
Subscribe for More Information
07:00 EDTDISCA21st Century Fox says 'no truth' in rumors of Discovery talks, Reuters reports
Subscribe for More Information
06:37 EDTSLXPSalix downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray downgraded Salix Pharmaceuticals (SLXP) to Neutral saying that while it could "easily see" another bidder emerge, it does not expect any potential competing bids to be significantly higher than the Valeant (VRX) offer. Piper lowered its price target for Salix shares to $158 from $160.
06:34 EDTDISCA21st Century Fox, Discovery held preliminary merger talks, AFR reports
21st Century Fox (FOXA) executives met with their counterparts at Discovery Communications (DISCA) nearly two weeks ago to discuss a possible takeover offer, The Australian Financial Review reports, citing sources. According to the sources, discussions were "nascent" and talks are in the "very, very early days." A spokesperson for 21st Century Fox has denied talks took place. Reference Link
06:05 EDTSLXPValeant to host conference call
Subscribe for More Information
05:52 EDTPANWCyberArk downgraded to Underweight from Neutral at JPMorgan
JPMorgan downgraded Cyberark Software (CYBR) to Underweight, its sell-equivalent, saying "a lot needs to go right" to justify the current valuation. JPMorgan keeps a $42 price target for the stock, well below Friday's closing price of $70.35. It points out that CyberArk's valuation is in-line with Palo Alto Networks (PANW), despite the latter company's total addressable market being roughly five times larger in its estimation. Cyberark is an Israel-based security company offering protections against cyber attacks.
February 22, 2015
16:07 EDTSLXPValeant confirms acquiring Salix for $158 per share
Valeant Pharmaceuticals International (VRX) and Salix Pharmaceuticals (SLXP) announced that they have entered into a definitive agreement under which Valeant will acquire all of the outstanding common stock of Salix for $158 per share in cash, or a total enterprise value of approximately $14.5B. The transaction was approved by the Boards of Directors of both companies. Salix Pharmaceuticals is a widely recognized gastrointestinal market leader with a portfolio of 22 total products, including well-known prescription brands Xifaxan, Uceris, Relistor, and Apriso, as well as a strong near- term pipeline of innovative, new assets. "Salix's market-leading gastrointestinal franchise is an ideal strategic fit for Valeant's diversified portfolio of specialty products," said J. Michael Pearson, Valeant's chairman and CEO. "The growing GI market has attractive fundamentals, and Salix has a portfolio of terrific products that are outpacing the market in terms of volume growth and a promising near-term pipeline of innovative products. With strong brand recognition among specialist GI prescribers, a highly rated specialty sales force, and a significant product and commercial presence across the undertreated and underserved gastrointestinal market, this acquisition offers a compelling opportunity for Valeant to create a strong platform for growth and business development." The combination is expected to yield greater than $500M in annual cost savings from the cost base of the combined company. Synergies are expected to be achieved within six months of close, primarily from reductions in corporate overhead and R&D rationalization, with the cost to achieve these synergies to be approximately 65%. Valeant and Salix will determine how best to integrate the two companies to leverage the combined strengths of both while ensuring a smooth and orderly transition. Consistent with Valeant's approach to integrating Bausch + Lomb, there are no planned reductions to Salix's highly rated specialty sales forces or hospital, key account and field reimbursement teams and we will determine the optimal size of Primary Care Sales Force through the integration process.The acquisition is structured as an all-cash tender offer for all of the outstanding shares of Salix common stock at a price of $158 per share followed by a merger in which each remaining untendered share of Salix common stock would be converted into the right to receive the same $158 cash per share consideration as in the tender offer. The all-cash offer will be financed through a combination of bank debt and bonds. As a result of the need to draw down inventories, EBITDA will be artificially low in 2014 and 2015, resulting in the initial net leverage ratio of approximately 5.6. Valeant is committed to reducing its net leverage ratio to be below 4.0 by the second half of 2016. As a result of the plan to reduce wholesaler inventory levels in 2015, the transaction is expected to be modestly accretive to 2015 cash EPS, but over 20% accretive to 2016 cash EPS. Valeant does not expect any change to its credit ratings as a result of the transaction. The transaction, which is expected to close in the second quarter of 2015, is subject to customary closing conditions and regulatory approval.
15:59 EDTSLXPValeant to buy Salix for $10.1B, FT says
Subscribe for More Information
February 20, 2015
09:45 EDTSLXPValeant near deal to acquire Salix, CNBC's Faber reports
Subscribe for More Information
09:43 EDTSLXPValeant nearing deal to acquire Salix, CNBC's Faber reports
Subscribe for More Information
07:08 EDTSLXP, ABTAmerican Academy of Allergy, Asthma and Immunology to hold annual meeting
2015 Annual Meeting of AAAAI is being held in Houston, Texas on February 20-24.
February 19, 2015
14:46 EDTSCORcomScore announces global integration with Flurry from Yahoo
comScore (SCOR announced an integration with Flurry through Yahoo's (YHOO) Flurry Pulse solution, which will enable Flurry clients to streamline application tagging required for unified measurement in comScore Mobile Metrix and Media Metrix Multi-Platform. The beta period for this integration is expected to begin in the second quarter of 2015.
09:14 EDTAOLAOL reports AOL Mail outages
Subscribe for More Information
07:25 EDTDISCACable nets speed up shows to add more ads, WSJ says
Subscribe for More Information
07:08 EDTDISCADiscovery reports Q4 EPS 43c, consensus 41c
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use